Page last updated: 2024-08-21

dronabinol and Dilatation, Pathologic

dronabinol has been researched along with Dilatation, Pathologic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Cheng, J; Derakhshandeh, R; Guo, R; Han, DD; Liu, J; Murphy, MB; Nabavizadeh, P; Rao, P; Schick, SF; Springer, ML1
Boeckxstaens, GE; Klooker, TK; Leliefeld, KE; Van Den Wijngaard, RM1

Trials

1 trial(s) available for dronabinol and Dilatation, Pathologic

ArticleYear
The cannabinoid receptor agonist delta-9-tetrahydrocannabinol does not affect visceral sensitivity to rectal distension in healthy volunteers and IBS patients.
    Neurogastroenterology and motility, 2011, Volume: 23, Issue:1

    Topics: Adult; Analgesics, Non-Narcotic; Cannabinoid Receptor Agonists; Cross-Over Studies; Dilatation, Pathologic; Double-Blind Method; Dronabinol; Female; Humans; Hyperalgesia; Irritable Bowel Syndrome; Middle Aged; Pain Threshold; Placebos; Pressure; Rectum; Viscera; Young Adult

2011

Other Studies

1 other study(ies) available for dronabinol and Dilatation, Pathologic

ArticleYear
Impairment of Endothelial Function by Aerosol From Marijuana Leaf Vaporizers.
    Journal of the American Heart Association, 2023, Dec-05, Volume: 12, Issue:23

    Topics: Aerosols; Animals; Cannabinoids; Cannabis; Dilatation, Pathologic; Dronabinol; Electronic Nicotine Delivery Systems; Marijuana Smoking; Nebulizers and Vaporizers; Nicotiana; Plant Leaves; Rats; Smoke

2023